Apoptosis-associated proteins and the development of oral squamous cell carcinoma

Oral Oncology

Volumn 35, Issue 1, 1999, Pages 77-85

  Schoelch, M L ^a   Le, Q T ^b   Silverman Jr , S ^a   McMillan, A ^a   Dekker, N P ^a   Fu, K K ^a   Ziober, B L ^a   Regezi, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; bcl 2; Immunohistochemistry; Oral leukoplakia; p53; Squamous cell carcinoma

Indexed keywords

PROTEIN BAX; PROTEIN P53; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; APOPTOSIS; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032889747     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00065-7     Document Type: Article

References (59)

1. Kerr J.F.R., Searle J. A suggested explanation for the paradoxically slow growth rate of basal-cell carcinoma that contain numerous mitotic figures. Journal of Pathology. 107:(1):1972;41-44.
2. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer. 26:(4):1972;239-257.
3. Hockenbery D. Defining apoptosis. American Journal of Pathology. 146:(1):1995;16-19.
4. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73:(8):1994;2013-2026.
5. Green D.R., McGahon A., Martin S.J. Regulation of apoptosis by oncogenes. Journal of Cellular Biochemistry. 60:(1):1996;33-38.
6. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Reviews. 11:(2):1992;95-103.
7. Tsujimoto Y., Croce C.M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proceedings of the National Academy of Sciences USA. 83:(14):1986;5214-5218.
8. Tsujimoto Y., Louie E, Bashir M.M., Croce C.M. The reciprocal partners of both the t(14;18) and t(11;14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene. 2:(4):1988;347-351.
9. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:(6189):1988;440-442.
10. Cazals-Hatem D., Louie D., Tanaka S., Reed J.C. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the bcl-2 oncoprotein. Biochimica Biophysica Acta. 1132:(1):1992;109-113.
11. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W, Reed J.C. Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Research. 53:(19):1993;4701-4714.
12. Oltvai Z., Milliman C., Korsmeyer S.J. Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:(4):1993;609-619.
13. Boise L.H., Gonzalea-Garcia M., Postema C.E., et al. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:(4):1993;597-608.
14. Kozopas K.M., Yang T., Buchan H.L., Zhou R, Craig R. Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proceedings of the National Academy of Sciences USA. 90:(8):1993;3516-3520.
15. Lin E.Y., Orlofsky A., Berger M.S., Prystowsky M.B. Characterization of A1, a novel hemopoietic-specific early response gene with sequence similarity to bcl-2. Journal of Immunology. 151:(4):1993;1979-1988.
16. Yang E., Xha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad: a heterodimeric partner for Bcl-X-L and Bcl-2, displaces Bax and promotes cell death. Cell. 80:(2):1995;285-291.
17. Chittenden T., Harrington E.A., O'Connor R., et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:(6524):1995;733-736.
18. Kiefer M.C., Brauer M.J., Powers V.C., et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:(6524):1995;736-739.
19. Farrow S.N., White J.H., Martinou I., et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:(6524):1995;731-733.
20. Reed J.C., Miyashita T., Takayama S., et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. Journal of Cellular Biochemistry. 60:(1):1996;23-32.
21. Park J.R., Hockenberry D.M. BCL-2, a novel regulator of apoptosis. Journal of Cellular Biochemistry. 60:(1):1996;12-17.
22. Farrow S.N., Brown R. New members of the Bcl-2 family and their protein partners. Current Opinion in Genetics and Development. 6:(11):1996;45-49.
23. Sato T., Hanada M., Bodrug S., et al. Interactions among members of the bcl-2 protein family analyzed with a yeast two hybrid system. Proceedings of the National Academy of Sciences USA. 91:(20):1994;9238-9242.
24. Sato T., Hanada M., Bodrug S., et al. Correction: Interactions among members of the Bcl-2 protein family analyzed with a yeast two hybrid system. Proceedings of the National Academy of Science USA. 92:(5):1995;2016.
25. Sedlak T.W., Oltvai Z.N., Yang E., et al. Multiple bcl-2 family members demonstrate selective dimerizations with Bax. Proceedings of the National Academy of Sciences USA. 92:(17):1995;7834-7838.
26. Ink B., Zornig M., Baum B., et al. Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells. Molecular and Cellular Biology. 17:(5):1997;2468-2474.
27. Tao W., Kurschner C., Morgan J.I. Modulation of cell death in yeast by the Bcl-2 family of proteins. Journal of Biological Chemistry. 272:(24):1997;15 547.
28. Jurgensmeier J.M., Krajewski S., Armstrong R.C., et al. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Molecular Biology of the Cell. 8:(2):1997;325-339.
29. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:(3):1997;323-331.
30. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature. 351:(6326):1991;453-456.
31. Ryan J.J., Danish R., Gottleib C.A., Clarke M.F. Cell cycle analysis of p53 induced cell death in murine erythroleukemia cells. Molecular and Cellular Biology. 13:(1):1993;711-719.
32. Cross S.M., Sanchez C.A., Morgan C.A., et al. A p53-dependent mouse spindle checkpoint. Science. 267:(5202):1995;1353-1356.
33. Fukasawa K., Choi T., Kuriyama R., Rulong S., Vande Woude G.F. Abnormal centrosome amplification in the absence of p53. Science. 271:(5256):1996;1744-1747.
34. Bond J.A., Blaydes J.P., Rowson J., et al. Mutant p53 rescues human diploid cells from senecsence without inhibiting the induction of SDI1/WAF1. Cancer Research. 55:(11):1995;2404-2409.
35. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Research. 54:(12):1994;3131-3135.
36. Miyashita T., Krajewski S., Krajewski M., et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:(6):1994;1799-1805.
37. Fakharzadeh S., Trusko S.P., George D.L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO Journal. 10:(6):1991;1565-1569.
38. Crook T., Wrede D., Tidy J.A., Mason W.P., Evans D.J., Vousden K.H. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumors. Lancet. 339:(8801):1992;1070-1073.
39. Huibregtse J.M., Scheffner M., Howley P.M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Molecular and Cellular Biology. 13:(2):1993;775-784.
40. Szekely L., Selivanova G., Magnusson K., Klein G., Wiman K. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proceedings of the National Academy of Science USA. 90:(12):1993;5455-5459.
41. Zhang Q., Gutsch D., Kenny S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Molecular and Cellular Biology. 14:(3):1994;1929-1938.
42. Oliner J.D., Kinzier K.W., Meltzer P.S., George D.L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 358:(6381):1992;80-83.
43. Momand J., Zambetti G.P., Olson D.C., George D.L., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:(7):1992;1237-1245.
44. Wahi P.N., Cohen B., Luthra U.K., Torioni H. International Histological Classification of Tumours No. 4: Histologic Typing of Oral and Oropharyngeal Tumours. Geneva: World Health Organization, 1971.
45. Krajewski S., Krajewska M., Shabaik A., et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Research. 54:(21):1994;5501-5507.
46. Sattler M., Liang H., Nettesheim D., et al. Structure of Bcl-X-L-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:(5302):1997;983-986.
47. Tao W., Kurschner C., Morgan J.I. Modulation of cell death in yeast by the Bcl-2 family of proteins. Journal of Biological Chemistry. 272:(24):1997;15 547-52.
48. Boise L.H., Gonzalez-Garcia M., Postema C.E., et al. Bcl-X a Bd-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:(4):1993;597-608.
49. Cheng E.H., Levine B., Boise L.H., Thompson C.B., Hardwick J.M. Bax-independent inhibition of apoptosis by Bcl-XL. Nature. 379:(6565):1996;554-556.
50. Krajewski S., Krajewska M., Reed J.C. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Research. 56:(12):1996;2849-2855.
51. Krajewska M., Moss S.F., Krajewski S., Song K, Holt P.R., Reed J.C. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Research. 56:(10):1996;2422-2427.
52. Krajewska M., Fenoglio-Preiser C.M., Krajewski S., et al. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. American Journal of Pathology. 149:(5):1996;1449-1457.
53. Wynford-Thomas D. p53 in tumor pathology: can we trust immunochemistry? Journal of Pathology. 166 4:1992;329-330.
54. Wu X., Boyle J.H., Olson D.C., Levine A.J. The p53-mdm-2 autoregulatory feedback loop. Genes and Development 1993;7(7A): 1126-1132.
55. Hall P.A., Lane D.P. p53 in tumor pathology: can we trust immunohistochemistry? - revisited! Journal of Pathology. 172:(1):1994;1-4.
56. Oren M., Reich N.C., Levine A.J. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Molecular and Cellular Biology. 2:(4):1982;443-449.
57. Bartek J., Iggo R., Gannon J., Lane D.R. Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene. 5:(6):1990;893-899.
58. Iggo R., Gatter K., Bartek J., Lane D., Harris A.L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335:(8691):1990;675-679.
59. Fazeli A., Steen R.G., Dickinson S.L., et al. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proceedings of the National Academy of Sciences USA. 94:(19):1997;10 199-204.